“Treatment of Post-Transplantation Lymphoproliferative Disorders After Kidney Transplant With Rituximab and Conversion to M-TOR Inhibitor”. Colombia Medica, vol. 47, no. 4, Dec. 2016, pp. 196-02, https://doi.org/10.25100/cm.v47i4.1989.